|
1.
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: from genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2.
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar
|
|
4.
|
Zhang B, Wang Q and Pan X: MicroRNAs and
their regulatory roles in animals and plants. J Cell Physiol.
210:279–289. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Calin GA and Croce CM: Chromosomal
rearrangements and microRNAs: a new cancer link with clinical
implications. J Clin Invest. 117:2059–2066. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Braconi C and Patel T: MicroRNA expression
profiling: a molecular tool for defining the phenotype of
hepatocellular tumors. Hepatology. 47:1807–1809. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Ladeiro Y, Couchy G, Balabaud C, et al:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Mott JL: MicroRNAs involved in tumor
suppressor and oncogene pathways: implications for hepatobiliary
neoplasia. Hepatology. 50:630–637. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Qiu L, Fan H, Jin W, et al:
miR-122-induced down-regulation of HO-1 negatively affects
miR-122-mediated suppression of HBV. Biochem Biophys Res Commun.
398:771–777. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Wolffe AP and Matzke MA: Epigenetics:
regulation through repression. Science. 286:481–486. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Hanoun N, Delpu Y, Suriawinata AA, et al:
The silencing of microRNA 148a production by DNA hypermethylation
is an early event in pancreatic carcinogenesis. Clin Chem.
56:1107–1118. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gailhouste L, Gomez-Santos L, Hagiwara K,
et al: miR-148a plays a pivotal role in the liver by promoting the
hepatospecific phenotype and suppressing the invasiveness of
transformed cells. Hepatology. 58:1153–1165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wilson AS, Power BE and Molloy PL: DNA
hypomethylation and human diseases. Biochim Biophys Acta.
1775:138–162. 2007.PubMed/NCBI
|
|
16.
|
Xu Q, Jiang Y, Yin Y, et al: A regulatory
circuit of miR-148a/152 and DNMT1 in modulating cell transformation
and tumor angiogenesis through IGF-IR and IRS1. J Mol Cell Biol.
5:3–13. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Bernardino J, Roux C, Almeida A, et al:
DNA hypomethylation in breast cancer: an independent parameter of
tumor progression? Cancer Genet Cytogenet. 97:83–89. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Soares J, Pinto AE, Cunha CV, et al:
Global DNA hypomethylation in breast carcinoma: correlation with
prognostic factors and tumor progression. Cancer. 85:112–118. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Zhu A, Xia J, Zuo J, et al: MicroRNA-148a
is silenced by hypermethylation and interacts with DNA
methyltransferase 1 in gastric cancer. Med Oncol. 29:2701–2709.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Pan W, Zhu S, Yuan M, et al: MicroRNA-21
and microRNA-148a contribute to DNA hypomethylation in lupus
CD4+ T cells by directly and indirectly targeting DNA
methyltransferase 1. J Immunol. 184:6773–6781. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Egger G, Liang G, Aparicio A and Jones PA:
Epigenetics in human disease and prospects for epigenetic therapy.
Nature. 429:457–463. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Balaguer F, Link A, Lozano JJ, et al:
Epigenetic silencing of miR-137 is an early event in colorectal
carcinogenesis. Cancer Res. 70:6609–6618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Zhang JP, Zeng C, Xu L, Gong J, Fang JH
and Zhuang SM: MicroRNA-148a suppresses the epithelial-mesenchymal
transition and metastasis of hepatoma cells by targeting Met/Snail
signaling. Oncogene. Sep 9–2013.(Epub ahead of print).
|
|
25.
|
Han H, Sun D, Li W, et al: A
c-Myc-MicroRNA functional feedback loop affects
hepatocarcinogenesis. Hepatology. 57:2378–2389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Yan H, Dong X, Zhong X, et al: Inhibitions
of epithelial to mesenchymal transition and cancer stem cells-like
properties are involved in miR-148a-mediated anti-metastasis of
hepatocellular carcinoma. Mol Carcinog. Jul 17–2013.(Epub ahead of
print).
|
|
27.
|
Robertson KD, Uzvolgyi E, Liang G, et al:
The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate
mRNA expression in normal tissues and overexpression in tumors.
Nucleic Acids Res. 27:2291–2298. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Ahluwalia A, Hurteau JA, Bigsby RM and
Nephew KP: DNA methylation in ovarian cancer. II Expression of DNA
methyltransferases in ovarian cancer cell lines and normal ovarian
epithelial cells. Gynecol Oncol. 82:299–304. 2001.PubMed/NCBI
|
|
29.
|
Karpf AR and Matsui S: Genetic disruption
of cytosine DNA methyltransferase enzymes induces chromosomal
instability in human cancer cells. Cancer Res. 65:8635–8639. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Mizuno S, Chijiwa T, Okamura T, et al:
Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal
hematopoiesis and in acute and chronic myelogenous leukemia. Blood.
97:1172–1179. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Roll JD, Rivenbark AG, Jones WD and
Coleman WB: DNMT3b overexpression contributes to a hypermethylator
phenotype in human breast cancer cell lines. Mol Cancer. 7:152008.
View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Bian EB, Huang C, Ma TT, et al:
DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell
activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol.
264:13–22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Huang J, Wang Y, Guo Y and Sun S:
Down-regulated microRNA-152 induces aberrant DNA methylation in
hepatitis B virus-related hepatocellular carcinoma by targeting DNA
methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Braconi C, Huang N and Patel T:
MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor
suppressor gene expression by interleukin-6 in human malignant
cholangiocytes. Hepatology. 51:881–890. 2010.PubMed/NCBI
|
|
35.
|
Li J, Song Y, Wang Y, Luo J and Yu W:
MicroRNA-148a suppresses epithelial-to-mesenchymal transition by
targeting ROCK1 in non-small cell lung cancer cells. Mol Cell
Biochem. 380:277–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Liu X, Zhan Z, Xu L, et al:
MicroRNA-148/152 impair innate response and antigen presentation of
TLR-triggered dendritic cells by targeting CaMKIIalpha. J Immunol.
185:7244–7251. 2010. View Article : Google Scholar : PubMed/NCBI
|
